Medical Device News Magazine
HomeMARKET REPORTS

United States Chronic Obstructive Pulmonary Disease Market Analysis and Competitive Landscape Report 2022

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “US Chronic Obstructive Pulmonary Disease Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com‘s offering.

The report provides comprehensive insights into Chronic Obstructive Pulmonary Disease pipeline products, Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease market valuations and forecast, Chronic Obstructive Pulmonary Disease drugs sales and competitive landscape in the US.

The research is classified into seven sections – Chronic Obstructive Pulmonary Disease treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Chronic Obstructive Pulmonary Disease pipeline: Find out the products in clinical trials for the treatment of Chronic Obstructive Pulmonary Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Chronic Obstructive Pulmonary Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Chronic Obstructive Pulmonary Disease in the US
  • Chronic Obstructive Pulmonary Disease drugs: Identify key products marketed and prescribed for Chronic Obstructive Pulmonary Disease in the US, including trade name, molecule name, and company
  • Chronic Obstructive Pulmonary Disease drugs sales: Find out the sales revenues of Chronic Obstructive Pulmonary Disease drugs in the US
  • Chronic Obstructive Pulmonary Disease market valuations: Find out the market size for Chronic Obstructive Pulmonary Disease drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
  • Chronic Obstructive Pulmonary Disease drugs market share: Find out the market shares for key Chronic Obstructive Pulmonary Disease drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Chronic Obstructive Pulmonary Disease market analysis and sales trends
  • Track competitor drugs sales and market share in the US Chronic Obstructive Pulmonary Disease market
  • Track competitive developments in Chronic Obstructive Pulmonary Disease market and present key issues and learnings
  • Synthesize insights for Chronic Obstructive Pulmonary Disease market and products to drive business performance
  • Answer key business questions about the Chronic Obstructive Pulmonary Disease market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Chronic Obstructive Pulmonary Disease products
  • Supports decision making in R&D to long term marketing strategies

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

Phone: 561.316.3330

Medical Device News Magazine

© 2024 Medical Device News Magazine A Division of PTM Healthcare Marketing. | All rights reserved.